These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3276544)

  • 41. Combination of magnetic and chemocytotoxic cancer cell depletion for autologous bone marrow transplantation.
    Morecki S; Slavin S
    Isr J Med Sci; 1988; 24(9-10):488-93. PubMed ID: 3060442
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Successful purging of murine plasmacytoma by mafosfamide (ASTA-Z).
    Weiss L; Slavin G; Reich S; Sidi H; Slavin S
    Bone Marrow Transplant; 1994 Jan; 13(1):27-30. PubMed ID: 8019450
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Limiting dilution analysis for detection of residual leukemic cells after bone marrow combined decontamination with mafosfamide followed by merocyanine-540-mediated photosensitization.
    Porcellini A; Rossi MT; Manna A; Sparaventi G; Pazzaglia C
    Int J Cell Cloning; 1989 Jul; 7(4):223-31. PubMed ID: 2671163
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Normal blast colony formation: an in vitro tool for monitoring human bone marrow 'purging'.
    Degliantoni G; Mangoni L; Rizzoli V
    Bone Marrow Transplant; 1986 Dec; 1(2):209-13. PubMed ID: 3332133
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autologous bone marrow transplantation using marrow incubated with Asta Z 7557 in adult acute leukemia.
    Gorin NC; Douay L; Laporte JP; Lopez M; Mary JY; Najman A; Salmon C; Aegerter P; Stachowiak J; David R
    Blood; 1986 May; 67(5):1367-76. PubMed ID: 3516254
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Purging of G-CSF-mobilized peripheral autografts in acute leukemia with mafosfamide and amifostine to protect normal progenitor cells.
    Fauth F; Martin H; Sonnhoff S; Bialleck H; Wiesneth M; Mihanovic B; Hoelzer D
    Bone Marrow Transplant; 2000 Apr; 25(8):831-6. PubMed ID: 10808203
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of purging with multidrug resistance (MDR) modulators and VP-16: results of long-term marrow culture.
    Aihara M; Sikic BI; Blume KG; Chao NJ
    Exp Hematol; 1990 Sep; 18(8):940-4. PubMed ID: 2387345
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide.
    Ratajczak MZ; Ratajczak J; Kuczynski W; Light B; Lusk EJ; Gewirtz AM
    Exp Hematol; 1993 Dec; 21(13):1663-7. PubMed ID: 8243568
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autologous bone marrow transplantation for acute leukemia using transplant chemopurified with metabolite of oxazaphosphorines (ASTA Z 7557, INN mafosfamide). First clinical results.
    Hervé P; Cahn JY; Plouvier E; Flesch M; Tamayo E; Leconte des Floris R; Peters A
    Invest New Drugs; 1984; 2(2):245-52. PubMed ID: 6381384
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia.
    Kröger N; Zabelina T; Sonnenberg S; Krüger W; Renges H; Stute N; Finkenstein F; Mayer U; Holstein K; Fiedler W; Colberg H; Sonnen R; Kuse R; Braumann D; Metzner B; del Valle F; Erttmann R; Kabisch H; Zander AR
    Bone Marrow Transplant; 2000 Oct; 26(7):711-6. PubMed ID: 11042650
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Amifostine improves the antileukemic therapeutic index of mafosfamide: implications for bone marrow purging.
    Douay L; Hu C; Giarratana MC; Bouchet S; Conlon J; Capizzi RL; Gorin NC
    Blood; 1995 Oct; 86(7):2849-55. PubMed ID: 7670119
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protection of bone marrow stromal cells from the toxic effects of cyclophosphamide in vivo and of ASTA-Z 7557 and etoposide in vitro by ammonium trichloro(dioxyethylene-O-O')tellurate (AS101).
    Kalechman Y; Sotnik-Barkai I; Albeck M; Sredni B
    Cancer Res; 1993 Apr; 53(8):1838-44. PubMed ID: 8467503
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correlation of colony-forming cells, long-term culture initiating cells and CD34+ cells in apheresis products from patients mobilized for peripheral blood progenitors with different regimens.
    Bender JG; Lum L; Unverzagt KL; Lee W; Van Epps D; George S; Coon J; Ghalie R; McLeod B; Kaizer H
    Bone Marrow Transplant; 1994 Apr; 13(4):479-85. PubMed ID: 7517260
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sensitivity of human CFU-GM to mafosfamide: analysis of the factors affecting individual variations.
    Domenech J; Desbois I; Linassier C; Gihana E; Chenault S; Brémond JL; Colombat P; Lamagnère JP; Binet C
    Bone Marrow Transplant; 1993 Jun; 11(6):425-31. PubMed ID: 8334422
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Potential drugs for elimination of acute lymphatic leukemia cells from autologous bone marrow.
    Blaauw A; Spitzer G; Dicke K; Drewinko B; Vellekoop L; Zander A
    Exp Hematol; 1986 Aug; 14(7):683-8. PubMed ID: 2426131
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro chemoseparation of leukemic cells from murine bone marrow using VP16-213: importance of stem cell assays.
    Stiff PJ; Koester AR
    Exp Hematol; 1987 Mar; 15(3):263-8. PubMed ID: 3545881
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative effects of ASTA Z 7557 (INN mafosfamide) and cyclophosphamide on hematopoiesis in mice.
    Nowrousian MR; Schmidt CG
    Invest New Drugs; 1984; 2(2):207-13. PubMed ID: 6469516
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Peripheral blood progenitor cell transplantation: a single centre experience comparing two mobilisation regimens in 67 patients.
    Mahendra P; Johnson D; Scott MA; Jestice HK; Hood IM; Ager S; Bass G; Barker P; Boraks PA; Bloxham DM; Baglin TP; Marcus RE
    Bone Marrow Transplant; 1996 Apr; 17(4):503-7. PubMed ID: 8722346
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cumulative chemotherapy increases mafosfamide toxicity for normal progenitor cells in AML patients: rationale for cryopreserving adapted-dose purged marrow early in first complete remission.
    Martin H; Bruecher J; Claudé R; Hoelzer D
    Bone Marrow Transplant; 1993 Nov; 12(5):495-9. PubMed ID: 8298560
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recovery of the ability to induce immune resistance against L1210 lymphatic leukemia in semisyngeneic CD2F1 mice after lethal irradiation and reconstitution with bone marrow purged of leukemia with mafosfamide (ASTA Z 7654).
    Skórski T; Kawalec M
    Bone Marrow Transplant; 1987 Dec; 2(4):435-40. PubMed ID: 3332191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.